SCHEMBL10078026

SCHEMBL10078026

C=CC(=O)OCCCCOc1ccc(C(=O)Oc2ccc(C(=O)Oc3ccc(-c4ccc(OCCCCOC(=O)C=C)cc4)cc3)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.51
CYP3A4 P08684 2/20 0.48
NPC1 O15118 2/20 0.48
LMNA P02545 2/20 0.48
HTT P42858 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
TSHR P16473 2/20 0.47
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
PRSS1 P07477 1/20 0.45
ACR P10323 1/20 0.45
RARB P10826 4/20 0.45
MAPT P10636 3/20 0.44
KMT2A Q03164 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10078018 1.00 THRB (0.51) THRBCYP3A4NPC1LMNAHTT
SCHEMBL14346692 1.00 THRB (0.51) THRBCYP3A4NPC1LMNAHTT
SCHEMBL25501125 1.00 THRB (0.51) THRBCYP3A4NPC1LMNAHTT
SCHEMBL17301205 0.99 HTT (0.50) THRBCYP3A4NPC1LMNAHTT
SCHEMBL14088555 0.99 HTT (0.50) THRBCYP3A4NPC1LMNAHTT
SCHEMBL12650347 0.99 HTT (0.50) THRBCYP3A4NPC1LMNAHTT
SCHEMBL14075597 0.99 HTT (0.50) THRBCYP3A4NPC1LMNAHTT
SCHEMBL17301211 0.99 HTT (0.50) THRBCYP3A4NPC1LMNAHTT
SCHEMBL17301209 0.99 THRB (0.50) THRBCYP3A4NPC1LMNAHTT
SCHEMBL17301220 0.99 HTT (0.50) THRBCYP3A4NPC1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303926-A1 LIQUID CRYSTAL COMPOSITION, LIGHT ABSORPTION ANISOTROPIC LAYER, LAMINATE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-09-28 US disclosed
US-9383491-B2 Retardation film, polarizing plate, and liquid crystal display FUJIFILM CORPORATION (JP) 2016-07-05 US disclosed
US-9383491-B2 Retardation film, polarizing plate, and liquid crystal display FUJIFILM CORPORATION (JP) 2016-07-05 US disclosed
US-20160131809-A1 PHASE DIFFERENCE FILM, POLARIZATION PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2016-05-12 US disclosed
US-20160131809-A1 PHASE DIFFERENCE FILM, POLARIZATION PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2016-05-12 US disclosed
US-20150029445-A1 RETARDATION FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY FUJIFILM CORPORATION (JP) 2015-01-29 US disclosed
US-20150029445-A1 RETARDATION FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY FUJIFILM CORPORATION (JP) 2015-01-29 US disclosed
US-8094271-B2 Liquid crystal display device and color film plate, and processes for producing the same FUJIFILM CORPORATION (JP) 2012-01-10 US disclosed
US-8094271-B2 Liquid crystal display device and color film plate, and processes for producing the same FUJIFILM CORPORATION (JP) 2012-01-10 US disclosed
US-20110117295-A1 OPTICALLY ANISOTOPIC FILM, PROCESS FOR PRODUCING OPTICALLY ANISOTOPIC FILM, SUBSTRATE FOR LIQUID CRYSTAL CELL, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2011-05-19 US disclosed
US-7575696-B2 Liquid crystal composition and anisotropic material FUJIFILM CORPORATION (JP) 2009-08-18 US disclosed
US-20090087590-A1 OPTICALLY ANISOTROPIC FILM, METHOD OF PRODUCING THE SAME, AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
US-20090087590-A1 OPTICALLY ANISOTROPIC FILM, METHOD OF PRODUCING THE SAME, AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
US-20090040433-A1 LIQUID CRYSTAL DISPLAY DEVICE AND COLOR FILM PLATE, AND PROCESSES FOR PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2009-02-12 US disclosed
US-20090040433-A1 LIQUID CRYSTAL DISPLAY DEVICE AND COLOR FILM PLATE, AND PROCESSES FOR PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2009-02-12 US disclosed
US-20080023670-A1 LIQUID CRYSTAL COMPOSITION AND ANISOTROPIC MATERIAL FUJIFILM CORPORATION (JP) 2008-01-31 US disclosed
US-20080023670-A1 LIQUID CRYSTAL COMPOSITION AND ANISOTROPIC MATERIAL FUJIFILM CORPORATION (JP) 2008-01-31 US disclosed
US-20070286968-A1 Compound, liquid crystal composition, and their applications FUJIFILM CORPORATION (JP) 2007-12-13 US disclosed
US-20070286968-A1 Compound, liquid crystal composition, and their applications FUJIFILM CORPORATION (JP) 2007-12-13 US disclosed
WO-2007089040-A1 LIQUID CRYSTAL DISPLAY DEVICE AND COLOR FILM PLATE, AND PROCESSES FOR PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090087590-A1 OPTICALLY ANISOTROPIC FILM, METHOD OF PRODUCING THE SAME, AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME PYM1, OCIAD1, OCIAD2 THRB 3907/4885CYP3A4 2129/4885NPC1 1397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.